Emerging PKP technologies: Alphabet soup of corneal surgery

Article

The future of penetrating keratoplasty (PKP) may be "a lot more work, but no more money" as Michael Belin, MD, of the United States jokingly described it Monday, but the number of PKP procedures are definitely presenting options for the corneal surgeon.

The future of penetrating keratoplasty (PKP) may be "a lot more work, but no more money" as Michael Belin, MD, of the United States jokingly described it Monday, but the number of PKP procedures are definitely presenting options for the corneal surgeon.

Dr. Belin provided an overview of the new PKP procedures in his presentation, "PKP: Emerging Technologies" at the World Ophthalmology Congress. He outlined each procedure - listing the advantages, disadvantages and what each procedure brings to the table for corneal PKP.

He pointed out that all corneal surgeons are familiar with PKP. The procedure has a rapid surgical time (less than 1 hour). The requirements are minimal. There is little equipment and no optical interface. It has a long, successful track record. It also has a number of disadvantages. The biggest is that PKP is an open-eye procedure and it has long period of rehabilitation with unpredictable outcomes.

"Leave it up to us to take something that was simple and apply modern technology, modern techniques, and make something that is more complicated, takes longer, pays less," added Dr. Belin. "That's the price you pay for progress."

Dr. Belin reviewed each of the newer PKP techniques. "Unfortunately, what we have is the alphabet soup of corneal surgery," he said. Basically, technology has taken a "full-thickness procedure" and broken it down to different layers.

Automated lamellar therapeutic keratoplasty (ALTK) is the same as lamellar keratoplasty, but the procedure is now done with a microkeratome. He cited both the advantages and disadvantages of the procedure.

He then outlined the advantages of endothelial lamellar keratoplasty (ELK) and deep lamellar endothelial keratoplasty (DLEK). ELK has fallen among surgeons because the results of the procedure have been disappointing. The key to DLEK is the preparation of the host and preparation of the donor lenticle. Dr. Belin described the procedure in detail, outlining the advantages and disadvantages, as well as potential complications.

He also discussed descemets stripping endothelial keratoplasty (DSEK) and synthetic keratoprosthesis, including the Alpha-Cor procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.